|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 239.32 USD | -2.44% |
|
-1.93% | +15.38% |
| 01:33am | US FDA approves Johnson & Johnson's blood cancer drug after speedy review | RE |
| 01:29am | Johnson & Johnson's Janssen Biotech Unit Secures US FDA Approval for Multiple Myeloma Treatment | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 248.56 | 248.56 | 248.43 |
| Spread/Res. | -3.93% | -3.93% | -3.88% |
| Spread/Supp. | +2.58% | +16.87% | +23.58% |
| Support | 232.78 | 204.31 | 193.22 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- JNJ Stock
- Charts Johnson & Johnson
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition